To verify the prognostic value of NUCKS1, the expression was correlated with clinicopathological features, including grading, lymph node involvement, distant metastasis and the presence of other breast cancer markers (PR, ER, HER2, Ki-67 and CK 5/6). The gene discussed is ERBB2; the disease is breast cancer.